HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

IGFBPs are involved in xenograft development in nude mice.

AbstractBACKGROUND:
The insulin-like growth factors (IGFs) are involved in the growth and differentiation of neuroblastoma cells. In all biological fluids, they are non-covalently bound to high-affinity binding proteins (IGFBP-1 to -6) which modulate their bioavailability. We previously showed that IGFBP-6 expression is linked to the arrest of growth in neuroblastoma cells, whereas IGFBP-2 is associated with proliferation.
PROCEDURE:
To study the role of IGFBP-6 in cell growth, we stably IGR-N-91 neuroblastoma cells with a plasmid containing sequences coding for IGFBP-6 under the control of the cytomegalovirus (CMV) promoter.
RESULTS:
The incidence and size of tumors generated by injecting IGFBP-6-expressing cells into nude mice were reduced by factors of 2 and 5, respectively, as compared with those generated by injection by control cells. Northern blot analyses if xenografts revealed weaker expression of IGF-II, type 2 IGF receptor and IGFBP-2 mRNAs in IGFBP-6-expressing cthan in control xenografts. IGFBP-6 may therefore reduce the expression of IGF-II (which induces tumour development) at a transcriptional level. Conversely, containing IGFBP-2 cDNA under the control of CMV promoter grew three to four times as fast as normal control xenografts. Northern blot analyses revealed weaker expression of intact IGFBP-3 and IGFBP-1 in IGFBP-2-expressing than in control xenografts.
CONCLUSIONS:
IGFBP-1 and intact IGFBP-3 expression both enhance IGF bioavailability which promotes tumour growth. Although the mechanisms of action of IGFBP-2 and IGFBP-6 remain to be elucidated, an inverse relationship appears to exist between the two binding proteins, IGFBP-2 being involved in proliferation and IGFBP-6 in its arrest.
AuthorsS Babajko, P Grellier, B de Gallé, M Menouny, M Binoux
JournalMedical and pediatric oncology (Med Pediatr Oncol) Vol. 36 Issue 1 Pg. 154-6 (Jan 2001) ISSN: 0098-1532 [Print] United States
PMID11464872 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Insulin-Like Growth Factor Binding Protein 2
  • Insulin-Like Growth Factor Binding Protein 6
  • Insulin-Like Growth Factor Binding Proteins
  • Recombinant Fusion Proteins
  • Insulin-Like Growth Factor I
  • Insulin-Like Growth Factor II
Topics
  • Animals
  • Biological Availability
  • Cytomegalovirus (genetics)
  • Genes, Synthetic
  • Graft Survival
  • Humans
  • Insulin-Like Growth Factor Binding Protein 2 (genetics, physiology)
  • Insulin-Like Growth Factor Binding Protein 6 (genetics, physiology)
  • Insulin-Like Growth Factor Binding Proteins (physiology)
  • Insulin-Like Growth Factor I (physiology)
  • Insulin-Like Growth Factor II (physiology)
  • KB Cells (metabolism, transplantation)
  • Mice
  • Mice, Nude
  • Mitosis
  • Neoplasm Transplantation (physiology)
  • Neuroblastoma (pathology)
  • Promoter Regions, Genetic
  • Recombinant Fusion Proteins (physiology)
  • Transfection
  • Transgenes
  • Transplantation, Heterologous (physiology)
  • Tumor Cells, Cultured (metabolism, transplantation)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: